Skip to Content
July 18, 2023  •  Podcast

eCTD 4.0 and Standardized Data with Ben Wimmer

Changes are coming to regulatory submissions publishing and we talk about two of them, eCTD 4.0 and standardized data, with Ben Wimmer.

Read More
May 23, 2023  •  Podcast

Weight of Evidence vs Carcinogenicity Testing (Part 2) with Bruce Pearce and James Taylor

On this episode of Insight at Biologics, Bruce Pearce continues sharing his insight about the new ICH guidance which may allow you to forego animal carcinogenicity testing in favor of a weight of the evidence argument.

Read More
April 18, 2023  •  Podcast

“Weight of Evidence vs Carcinogenicity Testing (Part 1)” with Bruce Pearce

The ICH has released a new guidance which may allow you to forgo animal carcinogenicity testing in favor of a weight of the evidence argument. We begin our two-part discussion of why this has been added, including the goals of the addendum, on this episode of Insight at Biologics featuring expert Bruce Pearce. And, tune in next time for part 2 to find out how to go about this.

Read More
March 21, 2023  •  Podcast

“Navigating Institutional Memory & Preserving Knowledge” with Kerin Ablashi

In this episode of Insight at Biologics, industry expert Kerin Ablashi delves into institutional memory and knowledge management in the pharmaceutical industry. Discover exactly what institutional memory is, the role it plays in regulatory compliance, operations, and product development, as well as how you can develop knowledge management systems and continuity plans to support your organization, no matter what size.

Read More
March 7, 2023  •  Podcast

“Understanding Cell & Gene Therapy Potency Assay Development” with Diana Colleluori

In this episode of Insight at Biologics, industry expert, Diana Colleluori, explains everything that cell & gene therapy manufacturers need to know about potency assays. Learn about the definition, FDA guidances and regulations, best practices, and how to overcome the hurdles in potency assay development on this episode of Insight at Biologics.

Read More
February 9, 2023  •  Podcast

“How To Maximize Your Product’s Potential with a Regulatory Consulting Group” with HeeSun Smaldore

On this episode of Insight at Biologics, HeeSun Smaldore, Business Unit Lead, shares some helpful thoughts about the intricacies of deciding when to hire an outside consultant.

Read More
January 10, 2023  •  Podcast

“Understanding The IND Review Process” with Dr. Emily Place

On this episode of Insight at Biologics, Senior Consultant and industry expert Dr. Emily Noonan Place from Biologics Consulting chats with James Taylor about IND submissions and the review process. The fact is that the regulatory agency doesn't get a lot of time with your IND submission. How, then, does one optimize their IND submission to make the most of the allotted time in the review? And, how do you avoid the most common pitfalls? Find out all of this and more on this episode of Insight at Biologics.

Read More
December 13, 2022  •  Podcast

Gap Analysis with David Pepperl

How does one know if you may have all the correct information for making a drug or device submission? A gap analysis from experienced experts can actually save you time and money! David Pepperl explains more in this episode of Insight at Biologics.

Read More
November 22, 2022  •  Podcast

In vivo Cell Therapy with Robert Kutner

Using your own cells to help you heal isn't science fiction anymore. Robert Kutner takes us into the exciting world of in vivo cell therapy.

Read More
November 1, 2022  •  Podcast

What a Consultant Can Do For You with Debra Barngrover

Bringing a drug or device to market can be arduous. In this interview with Debra Barngrover of Biologics Consulting, we learn how a consultant can help bring your picture into focus.

Read More